Glioma-expressed antigen 2 (GLEA2): A novel protein that can elicit immune responses in glioblastoma patients and some controls

Clinical and Experimental Immunology

Volumn 126, Issue 2, 2001, Pages 206-213

  Fischer, U ^a   Struss, A K ^a   Hemmer, D ^a   Pallasch, C P ^a   Steudel, W I ^b   Meese, E ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Antigen; Glioma; Immune response

Indexed keywords

ANTIGEN; COMPLEMENTARY DNA; GLIOMA EXPRESSED ANTIGEN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; BLOOD SAMPLING; BRAIN TUMOR; CHROMOSOME 20; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; GLIOBLASTOMA; HUMAN; HYBRID CELL; HYBRIDIZATION; IMMUNE RESPONSE; IMMUNOBLOTTING; MALIGNANT NEOPLASTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SURVIVAL TIME; TUMOR CLASSIFICATION;

AMINO ACID SEQUENCE; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; ASTROCYTOMA; BASE SEQUENCE; BRAIN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 20; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENE EXPRESSION; GLIOMA; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034772612     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01635.x     Document Type: Article

References (20)

1. Highly anaplastic astrocytoma: A review of 357 patients treated between 1977 and 1989
2. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
3. p53 mutations in human malignant gliomas. Comparison of loss of heterozygosity with mutation frequency
4. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
5. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification
6. Tumor antigens in astrocytic gliomas
7. Human neoplasms elicit multiple specific immune responses in the autologous host
8. Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients
9. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer
10. Presence of circulating anti-c-myb oncogene product antibodies in human sera
11. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma
12. cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients
13. Twelve amplified and expressed genes localized in a single domain in glioma
14. Addendum: A technique for radiolabeling DNA restriction fragments to a high specific activity
15. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses
16. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins
17. Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab') 2 - A preliminary report
18. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
19. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII
20. Antigen localization regulates immune response in a dose- and time dependent fashion: Geographical view of immune reactivity